Back to Search Start Over

High-Throughput Screening for mTORC1/mTORC2 Kinase Inhibitors Using a Chemiluminescence-Based ELISA Assay.

Authors :
Shripad V. Bhagwat
Jennifer Kahler
Yan Yao
Paul Maresca
Maureen Brooks
Andy Crew
Michael Boisclair
Jonathan A. Pachter
Source :
Assay & Drug Development Technologies; Oct2009, Vol. 7 Issue 5, p471-478, 8p
Publication Year :
2009

Abstract

A high-throughput chemiluminescence and ELISA-based biochemical assay to identify mTORC1/mTORC2 kinase inhibitors is described. These mTOR complexes were isolated from HeLa whole cell lysate using mTOR antibodies and in-well immunoprecipitation. The integrity and purity of the mTORC1 and mTORC2 immunocomplexes were confirmed by western blotting. Full-length recombinant 4E-BP1 was used as a substrate and the catalytic activity was measured by detection of p4E-BP1 [T37/46] by a chemiluminescence method. The performance of this assay that can be used to identify dual mTORC1 and mTORC2 kinase inhibitors in a high-throughput 384-well format is described. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
1540658X
Volume :
7
Issue :
5
Database :
Complementary Index
Journal :
Assay & Drug Development Technologies
Publication Type :
Academic Journal
Accession number :
45422680
Full Text :
https://doi.org/10.1089/adt.2008.0183